Temocillin
- Generic Name
- Temocillin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H18N2O7S2
- CAS Number
- 66148-78-5
- Unique Ingredient Identifier
- 03QB156W6I
- Background
Temocillin has been investigated in Infection, Liver Dysfunction, and Urinary Tract Infection.
- Associated Conditions
- -
- Associated Therapies
- -
Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit
Phase 3
Recruiting
- Conditions
- SepsisSeptic Shock
- Interventions
- First Posted Date
- 2022-10-04
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 600
- Registration Number
- NCT05565222
- Locations
- 🇫🇷
MAYAUX Julien, Paris, France
🇫🇷LUYT Charles -Edouard, Paris, France
Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections
Phase 3
Completed
- Conditions
- Urinary Tract Infections
- Interventions
- First Posted Date
- 2018-06-01
- Last Posted Date
- 2021-04-19
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 29
- Registration Number
- NCT03543436
- Locations
- 🇫🇷
APHP - Saint-Antoine Hospital, Paris, France
🇫🇷CHU de Grenoble Hospital, Grenoble, France
🇫🇷Bichat hospital, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath